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journal homepage: www.elsevier.com/locate/jmhiLETTER TO THE EDITORCD44 and cancer nanotherapySir, the recent publication on the idea of using nanodrug
delivery system for help and treatment of human breast cancer
is very interesting [1]. Overall, the idea is interesting and if the
system is ﬁnally successful, it can be useful. However, some
concerns on the proposed system should be raised. First, the
tagging system is possible but the outcome of tagging needs
further studies. The change of the molecular size can be ex-
pected and the question is whether the ﬁnal molecule has a
shape that is ﬁt for further biological interaction or not. Also,
it is a basic rule in nanomedicine that change in size can result
in change in properties. Hence, the outcome molecule might
have several changes in biochemical, electrical and other prop-
erties. This might also affect the expected cancer therapy inter-
action. Finally, the CD44 is also presented at haematopoietic
system cell [2]. Whether the newly designed nanosystem causes
the haematological side effect requires further studies.2251-7294 ª 2012 published by Elsevier Ltd. on behalf of Teh
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